COVID-19 Pandemic Coverage
XTalks
SEPTEMBER 14, 2020
For their part, Johnson & Johnson published findings at the end of July in which they reported a single dose of their vector-based vaccine induced robust neutralizing antibody responses in rhesus macaques. Johnson & Johnson’s COVID-19 Vaccine. In fact, the infection rate across the US has doubled in less than one month.
92 
Let's personalize your content